Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Formycon And Zydus Partner For Exclusive Licensing And Supply Agreement Of Fyb206

Dec 9 (Reuters) - Formycon AG FYB.DE:

FORMYCON AND ZYDUS PARTNER FOR EXCLUSIVE LICENSING AND SUPPLY AGREEMENT OF FYB206, A BIOSIMILAR TO KEYTRUDA® (PEMBROLIZUMAB), IN THE U.S. AND CANADA

FORMYCON AG: UPON SIGNATURE OF AGREEMENT, CO TO BE ELIGIBLE TO RECEIVE MID-TEENS-MILLION-EURO UPFRONT & MILESTONE PAYMENTS IN 2025

Source text: ID:nGNX5xd11y

Further company coverage: FYB.DE

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zydus Lifesciences

See all news